86 related articles for article (PubMed ID: 10936496)
1. Decreased opioid-induced antinociception but unaltered G-protein activation in the genetic-diabetic NOD mouse.
Pieper GM; Mizoguchi H; Ohsawa M; Kamei J; Nagase H; Tseng LF
Eur J Pharmacol; 2000 Aug; 401(3):375-9. PubMed ID: 10936496
[TBL] [Abstract][Full Text] [Related]
2. Effects of a mu-opioid receptor agonist on G-protein activation in streptozotocin-induced diabetic mice.
Ohsawa M; Mizoguchi H; Narita M; Kamei J; Nagase H; Tseng LF
Eur J Pharmacol; 2000 Jul; 401(1):55-8. PubMed ID: 10915837
[TBL] [Abstract][Full Text] [Related]
3. The mu-opioid receptor gene-dose dependent reductions in G-protein activation in the pons/medulla and antinociception induced by endomorphins in mu-opioid receptor knockout mice.
Mizoguchi H; Narita M; Oji DE; Suganuma C; Nagase H; Sora I; Uhl GR; Cheng EY; Tseng LF
Neuroscience; 1999; 94(1):203-7. PubMed ID: 10613510
[TBL] [Abstract][Full Text] [Related]
4. Antagonistic property of buprenorphine for putative epsilon-opioid receptor-mediated G-protein activation by beta-endorphin in pons/medulla of the mu-opioid receptor knockout mouse.
Mizoguchi H; Wu HE; Narita M; Hall FS; Sora I; Uhl GR; Nagase H; Tseng LF
Neuroscience; 2002; 115(3):715-21. PubMed ID: 12435410
[TBL] [Abstract][Full Text] [Related]
5. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF
Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238
[TBL] [Abstract][Full Text] [Related]
6. Loss of mu-opioid receptor-mediated G-protein activation in the pons/medulla of mice lacking the exons 2 and 3 of mu-opioid receptor gene.
Mizoguchi H; Wu HE; Narita M; Loh HH; Nagase H; Tseng LF
Neurosci Lett; 2002 Dec; 335(2):91-4. PubMed ID: 12459506
[TBL] [Abstract][Full Text] [Related]
7. delta-Opioid receptor agonists produce antinociception and [35S]GTPgammaS binding in mu receptor knockout mice.
Hosohata Y; Vanderah TW; Burkey TH; Ossipov MH; Kovelowski CJ; Sora I; Uhl GR; Zhang X; Rice KC; Roeske WR; Hruby VJ; Yamamura HI; Lai J; Porreca F
Eur J Pharmacol; 2000 Feb; 388(3):241-8. PubMed ID: 10675732
[TBL] [Abstract][Full Text] [Related]
8. Differential involvement of mu(1)-opioid receptors in endomorphin- and beta-endorphin-induced G-protein activation in the mouse pons/medulla.
Mizoguchi H; Narita M; Wu H; Narita M; Suzuki T; Nagase H; Tseng LF
Neuroscience; 2000; 100(4):835-9. PubMed ID: 11036217
[TBL] [Abstract][Full Text] [Related]
9. Blockade of mu-opioid receptor-mediated G-protein activation and antinociception by TRK-820 in mice.
Mizoguchi H; Hung KC; Leitermann R; Narita M; Nagase H; Suzuki T; Tseng LF
Eur J Pharmacol; 2003 Feb; 461(1):35-9. PubMed ID: 12568913
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms responsible for the enhanced antinociceptive effects of micro-opioid receptor agonists in the rostral ventromedial medulla of male rats with persistent inflammatory pain.
Sykes KT; White SR; Hurley RW; Mizoguchi H; Tseng LF; Hammond DL
J Pharmacol Exp Ther; 2007 Aug; 322(2):813-21. PubMed ID: 17494863
[TBL] [Abstract][Full Text] [Related]
11. G protein activation by endomorphins in the mouse periaqueductal gray matter.
Narita M; Mizoguchi H; Narita M; Dun NJ; Hwang BH; Endoh T; Suzuki T; Nagase H; Suzuki T; Tseng LF
J Biomed Sci; 2000; 7(3):221-5. PubMed ID: 10810240
[TBL] [Abstract][Full Text] [Related]
12. Influence of a deletion of protein kinase C gamma isoform in the G-protein activation mediated through opioid receptor-like-1 and mu-opioid receptors in the mouse pons/medulla.
Narita M; Mizoguchi H; Khotib J; Suzuki M; Ozaki S; Yajima Y; Narita M; Tseng LF; Suzuki T
Neurosci Lett; 2002 Oct; 331(1):5-8. PubMed ID: 12359310
[TBL] [Abstract][Full Text] [Related]
13. Suppression of the morphine-induced rewarding effect and G-protein activation in the lower midbrain following nerve injury in the mouse: involvement of G-protein-coupled receptor kinase 2.
Ozaki S; Narita M; Narita M; Iino M; Miyoshi K; Suzuki T
Neuroscience; 2003; 116(1):89-97. PubMed ID: 12535942
[TBL] [Abstract][Full Text] [Related]
14. [(35)S]GTPĪ³S binding and opioid tolerance and efficacy in mouse spinal cord.
Madia PA; Navani DM; Yoburn BC
Pharmacol Biochem Behav; 2012 Mar; 101(1):155-65. PubMed ID: 22108651
[TBL] [Abstract][Full Text] [Related]
15. Mu and Delta opioid receptors activate the same G proteins in human neuroblastoma SH-SY5Y cells.
Alt A; Clark MJ; Woods JH; Traynor JR
Br J Pharmacol; 2002 Jan; 135(1):217-25. PubMed ID: 11786497
[TBL] [Abstract][Full Text] [Related]
16. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
17. Activation of G-proteins in the mouse pons/medulla by beta-endorphin is mediated by the stimulation of mu- and putative epsilon-receptors.
Mizoguchi H; Narita M; Nagase H; Tseng LF
Life Sci; 2000 Oct; 67(22):2733-43. PubMed ID: 11105989
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of spinal mu-opioid receptor function to activate G-protein by chronic naloxone treatment.
Narita M; Mizoguchi H; Nagase H; Suzuki T; Tseng LF
Brain Res; 2001 Sep; 913(2):170-3. PubMed ID: 11549382
[TBL] [Abstract][Full Text] [Related]
19. Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys.
Ko MC; Lee H; Harrison C; Clark MJ; Song HF; Naughton NN; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2003 Jul; 306(1):179-86. PubMed ID: 12676881
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein.
Alt A; McFadyen IJ; Fan CD; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2001 Jul; 298(1):116-21. PubMed ID: 11408532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
